Osimertinib vs Rosuvastatin
Osimertinib vs Rosuvastatin: Overview
This comparison examines the pharmacological differences between Osimertinib and Rosuvastatin.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Rosuvastatin: Competitive inhibitor of HMG-CoA reductase.
Pharmacokinetics
Half-life: Osimertinib β 48 hours; Rosuvastatin β 19 hours.
Chemical Properties
Molecular Formula: Osimertinib β C28H33N7O2; Rosuvastatin β C22H28FN3O6S.
Molecular Weight: Osimertinib β 499.6050 g/mol; Rosuvastatin β 481.5390 g/mol.
Type: Osimertinib β Small molecule; Rosuvastatin β Small molecule.